Physician profile
Lee Evans
NPI 1124077508
$56,135.26
in general payments reported to CMS, 2019-2025
34 companies · $29K in 2025
The $29K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $457 · 2021: $843 · 2022: $965 · 2023: $2,941 · 2024: $22K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Food and Beverage: $6,123 · Travel and Lodging: $5,771 · Consulting Fee: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $39,800.00 |
| Food and Beverage | $6,122.76 |
| Travel and Lodging | $5,771.38 |
| Consulting Fee | $1,575.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $51,872.62 | 2019-2025 | Advance Xp, Tactra, Ams 700 Cxr Rte Kit |
| Coloplast Corp | $1,003.35 | 2020-2025 | Titan |
| Janssen Biotech, INC. | $904.63 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $578.34 | 2019-2025 | Xtandi |
| Medtronic, INC. | $268.16 | 2021-2023 | Interstim |
| Procept Biorobotics Corporation | $199.80 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Sumitomo Pharma America, INC. | $129.55 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $125.82 | 2022-2025 | |
| Tolmar Pharmaceuticals, INC. | $115.34 | 2019-2022 | |
| Pfizer INC. | $112.61 | 2019-2025 | |
| Axonics, INC. | $95.85 | 2021-2023 | Axonics, Bulkamid |
| Innovation Technologies INC | $73.47 | 2022 | |
| 180 Medical, INC. | $64.15 | 2024-2025 | |
| Urogen Pharma, INC. | $52.02 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $48.93 | 2025 | Adstiladrin |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $46.00 | 2020 | |
| Urovant Sciences INC | $43.61 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $37.83 | 2022-2023 | Yonsa |
| Karl Storz Endoscopy-America | $36.56 | 2025 | |
| Tolmar, INC. | $35.83 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.36 | 2019-2020 | |
| Valencia Technologies Corporation | $26.88 | 2025 | Ecoin Device Kit |
| Baxter Healthcare | $23.55 | 2019 | |
| Merck Sharp & Dohme LLC | $23.06 | 2021 | |
| Teleflex LLC | $22.97 | 2024 | Urolift |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $22.79 | 2024 | Rexulti |
| Olympus America INC. | $21.07 | 2025 | Soltive, Bovie, Tecoflex |
| Blue Earth Diagnostics | $18.97 | 2021 | |
| Abc Home Medical Supply, INC. | $18.62 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.54 | 2025 | Caplyta |
| Laborie Medical Technologies Corp. | $16.73 | 2022 | |
| Endo Pharmaceuticals INC. | $15.79 | 2024 | Aveed, Xiaflex |
| Immunitybio, INC. | $15.62 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $14.84 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.